UK Edition
AdvertiseSubmit Company
Pharma JournalEvidence-Based Pharmaceutical Intelligence
CLINICAL RESEARCH

ACROSS Global

ACROSS Global logo

ACROSS Global

Visit WebsiteContact Company

About ACROSS Global

You get access to more than 8,000 research locations and an almost limitless number of potential clinical trial participants through our ACROSS Partners, who serve 99 countries. No of the size or nature of your company, the ACROSS GlobalTM Alliance streamlines international research.

Similar Companies

More in Clinical Research

I

iicon

A public-private partnership founded in the Liverpool City Region and supported by UKRI's Strength in Places Fund is known as iiCON. It was created to hasten the discovery and development of fresh, cutting-edge drugs and therapies for infectious illnesses with the goal of improving world health. Leading UK organisations working on infectious disease research and development are represented by iiCON, which is led by the Liverpool School of Tropical Medicine (LSTM). These organisations include the University of Liverpool, Unilever UK, the Liverpool University Hospitals NHS Foundation Trust, Infex Therapeutics, Evotec, and the AMR Centre, all of which are based in Alderley Park, Cheshire.

View profile
V

Vaccitech

Vaccitech is a firm that is working on creating products for the treatment and prevention of cancer and infectious diseases. Chimpanzee Adenovirus (prime) and MVA (boost), two components of the company's patented technology platform, are incredibly effective at stimulating, sustaining, and maintaining CD8+ and CD4+ T cells as well as antibodies. The Jenner Institute at the University of Oxford, one of the most esteemed vaccine research institutions in the world, has granted Vaccitech a licence to use its prime-boost platform. Vaccitech is about to launch its HPV and NSCLC medicines in the clinic and currently has a Phase 2a clinical programme for prostate cancer. In addition, the business is working on MERS coronavirus and Herpes zoster vaccines with international partners, and it has granted University of Oxford-AstraZeneca an outlicense for the ChAdOx COVID-19 vaccine.

View profile
A

AES

AES now includes Synexus, Acurian, and Optimal. The patient data that is completely identifiable belongs to AES. We also own the greatest network of clinical research facilities in the world.

View profile
AdvertisementTeksyte LTD

List Your Company

Showcase your company to thousands of pharma professionals.

Submit Listing

Advertise With Us

Reach decision-makers in the pharmaceutical industry.

Learn More

We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy